A Phase II clinical study of AL001, in healthy human subjects.
Latest Information Update: 23 May 2025
At a glance
- Drugs Lithium cocrystal Alzamend Neuro (Primary)
- Indications Alzheimer's disease
- Focus Pharmacokinetics; Therapeutic Use
Most Recent Events
- 23 May 2025 New trial record
- 19 May 2025 According to the Alzamend Neuro media release, company announced the enrollment of the first patient of its first Phase II clinical study of AL001, in healthy human subjects. topline data anticipated by the end of the year.